The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Plasma viral DNA as a marker of tumor response in EBV(+) Hodgkin lymphoma in a phase III study (E2496).
Jennifer Ann Kanakry
No relevant relationships to disclose
Hailun Li
No relevant relationships to disclose
Lan L. Gellert
No relevant relationships to disclose
M. Victor Lemas
No relevant relationships to disclose
Wen Son Hsieh
No relevant relationships to disclose
King L. Tan
No relevant relationships to disclose
Randy D. Gascoyne
No relevant relationships to disclose
Leo I. Gordon
No relevant relationships to disclose
Sandra J. Horning
No relevant relationships to disclose
Brad S. Kahl
No relevant relationships to disclose
Richard F. Ambinder
No relevant relationships to disclose